A gift from the Mancheski Foundation continues to provide integral support to doctoral student Matthew Zammit as he furthers his research on the progression of Alzheimer’s disease in individuals with Down syndrome. Zammit is beginning …
Month: December 2019
Major lifetime gift establishes scholarly society
It’s been seven years since Dick Morse, MD, a UW alum and retired child psychiatrist, and his lifelong partner, Lawrence M. Connor, MSW, a retired social worker, established an $11 million (now worth an estimated $17 million) planned estate gift for the Morse Society — a multidisciplinary graduate fellowship program at the Waisman Center.
Waisman Center 2019: Year-in-Review
2019 Year-in-Review
Low genetic risk for ADHD may protect against negative life experiences
A recent study shows that people at low genetic risk for attention deficit hyperactivity disorder (ADHD) are not only less likely to have the disorder, they also have better than expected economic, health and behavioral outcomes in later life.
Clinical trial for Ebola vaccine developed at UW–Madison underway in Japan
As of this week, a phase one clinical trial to test a potential new Ebola vaccine developed by researchers at the University of Wisconsin–Madison is underway in Japan. Fifteen healthy young men* will receive two doses of the experimental vaccine. If the first group tolerates the vaccine, an additional group of up to 20 volunteers will receive a higher dose of the vaccine.
Doug Dean, III, PhD – Slide of the Week
White matter microstructure, essential for efficient and coordinated transmission of neural communications, undergoes pronounced development during the first years of life, while deviations to this neurodevelopmental trajectory likely result in alterations of brain connectivity relevant to behavior. Hence, systematic evaluation of white matter microstructure in the normative brain is critical for a neuroscientific approach to both typical and atypical early behavioral development.